BDF Gestion Sells 691 Shares of McKesson Co. (NYSE:MCK)

BDF Gestion lowered its holdings in shares of McKesson Co. (NYSE:MCK) by 11.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,309 shares of the company’s stock after selling 691 shares during the quarter. BDF Gestion’s holdings in McKesson were worth $3,026,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of the business. Synergy Asset Management LLC bought a new stake in shares of McKesson in the 4th quarter worth about $32,000. Gries Financial LLC bought a new stake in shares of McKesson in the 4th quarter worth about $202,000. McKinley Carter Wealth Services Inc. lifted its holdings in shares of McKesson by 0.4% in the 4th quarter. McKinley Carter Wealth Services Inc. now owns 13,748 shares of the company’s stock worth $7,835,000 after acquiring an additional 61 shares during the last quarter. R Squared Ltd bought a new stake in shares of McKesson in the 4th quarter worth about $171,000. Finally, Gateway Wealth Partners LLC bought a new stake in shares of McKesson in the 4th quarter worth about $201,000. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on MCK. Citigroup lowered their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Baird R W raised shares of McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Evercore ISI raised their price target on shares of McKesson from $560.00 to $680.00 and gave the stock an “outperform” rating in a research note on Thursday, November 7th. Mizuho initiated coverage on shares of McKesson in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price target on the stock. Finally, Wells Fargo & Company raised their price target on shares of McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $646.14.

McKesson Stock Performance

NYSE MCK opened at $603.79 on Thursday. The company’s 50-day simple moving average is $592.16 and its two-hundred day simple moving average is $561.52. McKesson Co. has a one year low of $464.42 and a one year high of $637.51. The company has a market capitalization of $76.64 billion, a price-to-earnings ratio of 31.27, a price-to-earnings-growth ratio of 1.26 and a beta of 0.52.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The firm had revenue of $93.65 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the previous year, the firm earned $6.23 EPS. The company’s quarterly revenue was up 21.3% compared to the same quarter last year. Equities analysts expect that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.11% of the company’s stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.